Enspryng
Active substance: satralizumab
INJECTION, SOLUTION · SATRALIZUMAB 120 mg/mL
United StatesActive
Marketing holder: Genentech, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- SATRALIZUMAB · 120 mg/mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1209b-0e82-72e4-9497-37ef69b49d6a;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 50242-007
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 50242-007 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 50242-007 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 50242-007 · Verified 2026-10-09 · open in source